Charles Schwab’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-225,485
| Closed | -$6.08M | – | 3613 |
|
|
2022
Q4 | $6.08M | Buy |
225,485
+7,819
| +4% | +$211K | ﹤0.01% | 2120 |
|
|
2022
Q3 | $3.91M | Sell |
217,666
-5,056
| -2% | -$90.8K | ﹤0.01% | 2350 |
|
|
2022
Q2 | $2.77M | Buy |
222,722
+4,693
| +2% | +$58.3K | ﹤0.01% | 2454 |
|
|
2022
Q1 | $2.91M | Buy |
218,029
+5,868
| +3% | +$78.2K | ﹤0.01% | 2514 |
|
|
2021
Q4 | $3.3M | Buy |
212,161
+3,339
| +2% | +$52K | ﹤0.01% | 2546 |
|
|
2021
Q3 | $4.69M | Buy |
208,822
+16,007
| +8% | +$359K | ﹤0.01% | 2407 |
|
|
2021
Q2 | $4.39M | Buy |
192,815
+4,842
| +3% | +$110K | ﹤0.01% | 2413 |
|
|
2021
Q1 | $3.87M | Buy |
+187,973
| New | +$3.87M | ﹤0.01% | 2417 |
|
|
2017
Q2 | – | Sell |
-16,900
| Closed | -$199K | – | 3154 |
|
|
2017
Q1 | $199K | Hold |
16,900
| – | – | ﹤0.01% | 2932 |
|
|
2016
Q4 | $211K | Buy |
+16,900
| New | +$211K | ﹤0.01% | 2948 |
|